Reportable, Inc.: Health Canada Clears Pacylex Pharmaceuticals for New Phase 1 Clinical Trial to Evaluate PCLX-001 Capsules in the Treatment of Hematologic and Solid Tumor Cancers
Reportable, Inc.: Health Canada Clears Pacylex Pharmaceuticals for New Phase 1 Clinical Trial to Evaluate PCLX-001 Capsules in the Treatment of Hematologic and Solid Tumor Cancers Key Takeaways: Scientists at the University of Alberta have recently published evidence that a new drug could work in blood cancers by targeting B-cell signaling. Scientists at the University of Alberta also published a study showing potential in breast cancer. PCLX-001 led to significant tumor regression in mouse models, including completely eliminating lymphoma tumors derived from a patient whose cancer had stoppe...
Source: finanznachrichten.de
